Trolox clinical trials
Also written KH176 and Sonlicromanol.
How each study uses Trolox is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Trolox studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 1
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Trolox.
- Feb 2027Sonlicromanol in Post-COVIDPhase 2 · Michele van Vugt
Studies
Open first, then newest update. How each study uses Trolox is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial DiseasesRecruitingPhase 3Khondrion BVNCT06451757Written as Sonlicromanol
- Sonlicromanol in Post-COVIDRecruitingPhase 2Michele van VugtNCT07298005Written as Sonlicromanol
- The KHENERGYC StudySuspendedPhase 2Khondrion BVNCT04846036Written as Sonlicromanol
- The KHENERGYZE StudyCompletedPhase 2Khondrion BVNCT04165239Written as KH176
- A Dose-escalating Clinical Trial With KH176CompletedPhase 1Khondrion BVNCT02544217Written as KH176
- The KHENERGY StudyCompletedPhase 2Khondrion BVNCT02909400Written as KH176
Codes
What other systems call Trolox · ClinicalTrials.gg INT002498
- MeSH (NLM) C0106436-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S18UL9710X6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACIDConfirmed NLM, Wikidata
- Wikidata Q245489TroloxConfirmed NLM, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S18UL9710X | 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID | Confirmed NLM, Wikidata |
| Wikidata | Q245489 | Trolox | Confirmed NLM, Wikidata |
Also registered as sonlicromanol (UNII JCU3O35RDS).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.